Status:
COMPLETED
Methylphenidate Treatment for Cocaine Abuse and ADHD - 1
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Attention Deficit Disorder With Hyperactivity
Cocaine-Related Disorders
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
Brief Summary
Many cocaine dependent individuals are also diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Methylphenidate (Ritalin) is currently approved to treat individuals diagnosed with ADHD. Th...
Detailed Description
Methylphenidate (MPH) is commonly used to treat individuals diagnosed with ADHD. The purpose of this study is to determine the effectiveness of MPH in treating adult cocaine dependent individuals who ...
Eligibility Criteria
Inclusion
- Meets DSM-IV criteria for cocaine dependence
- Meets DSM-IV criteria for persistent adult Attention Deficit Hyperactive Disorder
Exclusion
- Meets DSM-IV criteria for current psychiatric disorders (other than ADHD or substance abuse) that requires a psychiatric intervention
- Physiologically dependent on sedatives or alcohol, to the extent that medical attention is required during periods of abstinence or significant reduction in the amount of use
- Exhibits suicidal or homicidal behavior within the two years prior to enrollment
- Currently taking prescription psychotropic medication
- Unstable medical condition (e.g., uncontrolled diabetes) that would make participation in the study hazardous
- Known sensitivity to methylphenidate
- Pregnant or breastfeeding
Key Trial Info
Start Date :
April 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2004
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT00136734
Start Date
April 1 1998
End Date
March 1 2004
Last Update
April 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Foundation for Mental Hygiene, Inc.
New York, New York, United States, 10032